Yoshitsugu Aoki - Search Results

Year	Number of Results
2006	1
2007	1
2010	2
2011	2
2012	2
2013	6
2014	1
2015	3
2016	6
2017	5
2018	10
2019	10
2020	10
2021	10
2022	10
2023	11
2024	2

1

The R436Q missense mutation in WWP1 disrupts autoinhibition of its E3 ubiquitin ligase activity, leading to self-degradation and loss of function.

Imamura M, Matsumoto H, Mannen H, Takeda S, Aoki Y. Imamura M, et al. Among authors: aoki y. In Vitro Cell Dev Biol Anim. 2024 Apr 1. doi: 10.1007/s11626-024-00894-3. Online ahead of print. In Vitro Cell Dev Biol Anim. 2024. PMID: 38561589

2

Characterization of CD90/Thy-1 as a crucial molecular signature for myogenic differentiation in human urine-derived cells through single-cell RNA sequencing.

Kunitake K, Motohashi N, Inoue T, Suzuki Y, Aoki Y. Kunitake K, et al. Among authors: aoki y. Sci Rep. 2024 Jan 28;14(1):2329. doi: 10.1038/s41598-024-52530-5. Sci Rep. 2024. PMID: 38282008 Free PMC article.

3

Establishment of a Triple Quadrupole HPLC-MS Quantitation Method for Dystrophin Protein in Mouse and Human Skeletal Muscle.

Tominari T, Takatoya M, Matsubara T, Matsunobe M, Arai D, Matsumoto C, Hirata M, Yoshinouchi S, Miyaura C, Itoh Y, Komaki H, Takeda S, Aoki Y, Inada M. Tominari T, et al. Among authors: aoki y. Int J Mol Sci. 2023 Dec 25;25(1):303. doi: 10.3390/ijms25010303. Int J Mol Sci. 2023. PMID: 38203473 Free PMC article.

4

Antioxidants restore store-operated Ca²⁺ entry in patient-iPSC-derived myotubes with tubular aggregate myopathy-associated Ile484ArgfsX21 STIM1 mutation via upregulation of binding immunoglobulin protein.

Sakai-Takemura F, Saito F, Nogami K, Maruyama Y, Elhussieny A, Matsumura K, Takeda S, Aoki Y, Miyagoe-Suzuki Y. Sakai-Takemura F, et al. Among authors: aoki y. FASEB Bioadv. 2023 Oct 26;5(11):453-469. doi: 10.1096/fba.2023-00069. eCollection 2023 Nov. FASEB Bioadv. 2023. PMID: 37936920 Free PMC article.

5

Inherited myogenic abilities in muscle precursor cells defined by the mitochondrial complex I-encoding protein.

Motohashi N, Minegishi K, Aoki Y. Motohashi N, et al. Among authors: aoki y. Cell Death Dis. 2023 Oct 19;14(10):689. doi: 10.1038/s41419-023-06192-2. Cell Death Dis. 2023. PMID: 37857600 Free PMC article.

6

Exon 44 skipping in Duchenne muscular dystrophy: NS-089/NCNP-02, a dual-targeting antisense oligonucleotide.

Watanabe N, Tone Y, Nagata T, Masuda S, Saito T, Motohashi N, Takagaki K, Aoki Y, Takeda S. Watanabe N, et al. Among authors: aoki y. Mol Ther Nucleic Acids. 2023 Sep 20;34:102034. doi: 10.1016/j.omtn.2023.102034. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 37854955 Free PMC article.

7

Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan.

Preethy S, Aoki Y, Minegishi K, Iwasaki M, Senthilkumar R, Abraham SJK. Preethy S, et al. Among authors: aoki y. Sci Rep. 2023 Oct 9;13(1):17008. doi: 10.1038/s41598-023-44330-0. Sci Rep. 2023. PMID: 37813938 Free PMC article.

8

Ensemble-Learning and Feature Selection Techniques for Enhanced Antisense Oligonucleotide Efficacy Prediction in Exon Skipping.

Zhu A, Chiba S, Shimizu Y, Kunitake K, Okuno Y, Aoki Y, Yokota T. Zhu A, et al. Among authors: aoki y. Pharmaceutics. 2023 Jun 24;15(7):1808. doi: 10.3390/pharmaceutics15071808. Pharmaceutics. 2023. PMID: 37513994 Free PMC article.

9

Mr. Takashi Onaka Memorial Oration: I. Updates on solutions to DMD.

Aoki Y. Aoki Y. J Stem Cells Regen Med. 2023 Apr 30;19(1):19-21. doi: 10.46582/jsrm.1901004. eCollection 2023. J Stem Cells Regen Med. 2023. PMID: 37366408 Free PMC article. No abstract available.

10

Systemic administration of the antisense oligonucleotide NS-089/NCNP-02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial.

Ishizuka T, Komaki H, Asahina Y, Nakamura H, Motohashi N, Takeshita E, Shimizu-Motohashi Y, Ishiyama A, Yonee C, Maruyama S, Hida E, Aoki Y. Ishizuka T, et al. Among authors: aoki y. Neuropsychopharmacol Rep. 2023 Jun;43(2):277-286. doi: 10.1002/npr2.12335. Epub 2023 Apr 3. Neuropsychopharmacol Rep. 2023. PMID: 37326950 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year